ZimVie Inc

This committee controls taxation, trade, and entitlement spending, including Medicare and Medicaid. These programs are major payers for healthcare services utilizing ZimVie's medical devices, making its decisions on reimbursement rates, coverage, and tax policy directly impactful on corporate valuations and profitability.

This committee allocates discretionary federal spending. Its subcommittees determine the precise funding for federal healthcare programs (e.g., VA, NIH) and research, directly influencing the demand and reimbursement landscape for medical devices.

This committee directly oversees the FDA, which is the primary regulatory body for medical devices like those produced by ZimVie, influencing product approval, safety standards, and market access. It also oversees the NIH, a source of research funding relevant to medical innovation.

This committee has direct oversight of antitrust laws and intellectual property. Patents are critical for medical device companies like ZimVie, and antitrust decisions could impact mergers and acquisitions within the sector.

This committee directly oversees the Department of Veterans Affairs, a significant provider of healthcare services. Its funding decisions and policy mandates directly impact the market for medical devices like those offered by ZimVie to veterans' hospitals and clinics.